title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors: is there a real link?
authors.affiliation: Ankara Research Hospital, Gastroenterology Clinic, Ankara, Turkey.
authors.forename: Murat
authors.initials: M
authors.lastname: Sarikaya
authors.forename: Levent
authors.initials: L
authors.lastname: Filik
authors.forename: Bilal
authors.initials: B
authors.lastname: Ergul
authors.forename: Zeynal
authors.initials: Z
authors.lastname: Doğan
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects; D000328:Adult; D064098:Esomeprazole / Q000009:adverse effects; D005260:Female; D006801:Humans; D064747:Lansoprazole / Q000009:adverse effects; D008274:Magnesium / Q000097:blood*; D008275:Magnesium Deficiency / Q000097:blood* / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects; D000077402:Pantoprazole; D010281:Parathyroid Hormone / Q000097:blood* / Q000172:deficiency; D010437:Peptic Ulcer / Q000188:drug therapy; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D064750:Rabeprazole / Q000009:adverse effects
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D010281:Parathyroid Hormone; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D064750:Rabeprazole; D000077402:Pantoprazole; D008274:Magnesium; D009853:Omeprazole; D064098:Esomeprazole